Hosein Kouros-Mehr, Ph.D.
Affiliations: | 2006 | University of California, San Francisco, San Francisco, CA |
Area:
role of the cellular microenvironment and intercellular communication in breast development and cancerGoogle:
"Hosein Kouros-Mehr"Mean distance: 12.57 | S | N | B | C | P |
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Littlepage LE, Ewald AJ, Alexander C, et al. (2020) Zena Werb (1945–2020) Cell Stem Cell. 27: 356-358 |
Littlepage LE, Ewald AJ, Alexander C, et al. (2020) Zena Werb (1945–2020) Developmental Cell. 54: 299-301 |
Phua YW, Nguyen A, Roden D, et al. (2015) MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene. Breast Cancer Research : Bcr. 17: 83 |
Chen Y, McGee J, Chen X, et al. (2014) Identification of druggable cancer driver genes amplified across TCGA datasets. Plos One. 9: e98293 |
Chu IM, Lai WC, Aprelikova O, et al. (2013) Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. Plos One. 8: e61125 |
Franci C, Zhou J, Jiang Z, et al. (2013) Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model. Plos One. 8: e58183 |
Littlepage LE, Adler AS, Kouros-Mehr H, et al. (2012) The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer Discovery. 2: 638-51 |
Bagri A, Kouros-Mehr H, Leong KG, et al. (2010) Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale. Trends in Molecular Medicine. 16: 122-32 |
Kouros-Mehr H, Kim JW, Bechis SK, et al. (2008) GATA-3 and the regulation of the mammary luminal cell fate. Current Opinion in Cell Biology. 20: 164-70 |
Kouros-Mehr H, Bechis SK, Slorach EM, et al. (2008) GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 13: 141-52 |